213 related articles for article (PubMed ID: 9642990)
1. [Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer].
Ogura Y; Sato K; Kato T; Saito K; Enomoto K
Nihon Hinyokika Gakkai Zasshi; 1998 May; 89(5):529-37. PubMed ID: 9642990
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
[TBL] [Abstract][Full Text] [Related]
3. [Expression of VEGF and tumor angiogenesis in bladder cancer].
Wang S; Xia T; Zhang Z; Kong X; Zeng L; Mi P; Xue Z
Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):34-6. PubMed ID: 11831983
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
[TBL] [Abstract][Full Text] [Related]
5. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
Guo ZH; Mei H; Huang J; Li SY
Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
[TBL] [Abstract][Full Text] [Related]
6. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of angiogenesis in superficial bladder cancer.
Stavropoulos NE; Bouropoulos C; Ioachim IE; Michael M; Hastazeris K; Tsimaris I; Kalogeras D; Liamis Z; Stefanaki S; Agnantis NI
Int Urol Nephrol; 2004; 36(2):163-7. PubMed ID: 15368686
[TBL] [Abstract][Full Text] [Related]
10. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
Perrotte P; Matsumoto T; Inoue K; Kuniyasu H; Eve BY; Hicklin DJ; Radinsky R; Dinney CP
Clin Cancer Res; 1999 Feb; 5(2):257-65. PubMed ID: 10037173
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
Wakui S; Furusato M; Sasaki S; Muto T; Takahashi H; Masaoka T; Ushigome S
Vet Pathol; 1999 Mar; 36(2):111-6. PubMed ID: 10098638
[TBL] [Abstract][Full Text] [Related]
12. Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?
Sağol O; Yörükoğlu K; Sis B; Tuna B; Ozer E; Güray M; Mungan U; Kirkali Z
Urology; 2001 May; 57(5):895-9. PubMed ID: 11337289
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
[TBL] [Abstract][Full Text] [Related]
15. Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis.
Feng CC; Wang PH; Ding Q; Guan M; Zhang YF; Jiang HW; Wen H; Wu Z
Urol Oncol; 2013 Feb; 31(2):241-6. PubMed ID: 21292512
[TBL] [Abstract][Full Text] [Related]
16. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.
Theodoropoulos VE; Lazaris ACh; Sofras F; Gerzelis I; Tsoukala V; Ghikonti I; Manikas K; Kastriotis I
Eur Urol; 2004 Aug; 46(2):200-8. PubMed ID: 15245814
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
[TBL] [Abstract][Full Text] [Related]
19. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
Takahashi Y; Cleary KR; Mai M; Kitadai Y; Bucana CD; Ellis LM
Clin Cancer Res; 1996 Oct; 2(10):1679-84. PubMed ID: 9816116
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
